AP
Actinium Pharmaceuticals Inc
🇺🇸XNYS.ATNMUnited StatesHealthcare
$1.26USDunchanged 0.00 (0%)OpenDelayed6:13 PM
Price$1.260.00 (0%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- New York Stock Exchange . XNYS
- Type
- Stock
- ISIN
- US00507W2061
- CUSIP
- 68274T102
Company
- Employees
- 25
- Headquarters
- New York, United States
- CEO
- Mr. Sandesh C. Seth M.B.A., M.S.
Market
- Shares outstanding
- 31.4M
- Market cap
- $39.53M
Highlights
- Market cap
- $39.53M
- EPS LTM
- -$0.75
- P/E LTM
- -1.30
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $90K-88.89%down year on year
- Net income
- -$23.47M+48.43%up year on year
- Gross margin
- 83.33%+6,650%up year on year
- Free cash flow
- -$22.98M+30.93%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.